260 related articles for article (PubMed ID: 12198663)
1. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
[TBL] [Abstract][Full Text] [Related]
2. Alterations of the cadherin-catenin cell adhesion system in cancers.
Kanai Y; Oda T; Shimoyama Y; Ochiai A; Oyama T; Yoshiura K; Akimoto S; Yamada T; Hirohashi S
Princess Takamatsu Symp; 1994; 24():51-62. PubMed ID: 8983063
[TBL] [Abstract][Full Text] [Related]
3. Expression of epithelial cadherin and alpha- and beta-catenins in nontumoral livers and hepatocellular carcinomas.
Ihara A; Koizumi H; Hashizume R; Uchikoshi T
Hepatology; 1996 Jun; 23(6):1441-7. PubMed ID: 8675162
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
5. Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study.
Ashida K; Terada T; Kitamura Y; Kaibara N
Hepatology; 1998 Apr; 27(4):974-82. PubMed ID: 9537436
[TBL] [Abstract][Full Text] [Related]
6. Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity.
Legoix P; Bluteau O; Bayer J; Perret C; Balabaud C; Belghiti J; Franco D; Thomas G; Laurent-Puig P; Zucman-Rossi J
Oncogene; 1999 Jul; 18(27):4044-6. PubMed ID: 10435629
[TBL] [Abstract][Full Text] [Related]
7. Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines.
Pierceall WE; Woodard AS; Morrow JS; Rimm D; Fearon ER
Oncogene; 1995 Oct; 11(7):1319-26. PubMed ID: 7478552
[TBL] [Abstract][Full Text] [Related]
8. Patterns of alpha- and beta-catenin and E-cadherin expression in colorectal adenomas and carcinomas.
van der Wurff AA; Vermeulen SJ; van der Linden EP; Mareel MM; Bosman FT; Arends JW
J Pathol; 1997 Jul; 182(3):325-30. PubMed ID: 9349236
[TBL] [Abstract][Full Text] [Related]
9. Beta-catenin expression in human cancers.
Takayama T; Shiozaki H; Shibamoto S; Oka H; Kimura Y; Tamura S; Inoue M; Monden T; Ito F; Monden M
Am J Pathol; 1996 Jan; 148(1):39-46. PubMed ID: 8546224
[TBL] [Abstract][Full Text] [Related]
10. Beta- and gamma-catenin expression in thyroid carcinomas.
Cerrato A; Fulciniti F; Avallone A; Benincasa G; Palombini L; Grieco M
J Pathol; 1998 Jul; 185(3):267-72. PubMed ID: 9771480
[TBL] [Abstract][Full Text] [Related]
11. Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis.
Devereux TR; Anna CH; Foley JF; White CM; Sills RC; Barrett JC
Oncogene; 1999 Aug; 18(33):4726-33. PubMed ID: 10467420
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin function.
Ewing CM; Ru N; Morton RA; Robinson JC; Wheelock MJ; Johnson KR; Barrett JC; Isaacs WB
Cancer Res; 1995 Nov; 55(21):4813-7. PubMed ID: 7585512
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the E-cadherin-catenin complexes in pancreatic carcinoma cell lines.
El-Hariry I; Jordinson M; Lemoine N; Pignatelli M
J Pathol; 1999 Jun; 188(2):155-62. PubMed ID: 10398158
[TBL] [Abstract][Full Text] [Related]
14. Correlation of E-cadherin expression and recurrence of hepatocellular carcinoma.
Huang GT; Lee HS; Chen CH; Sheu JC; Chiou LL; Chen DS
Hepatogastroenterology; 1999; 46(27):1923-7. PubMed ID: 10430370
[TBL] [Abstract][Full Text] [Related]
15. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo.
Hennig G; Behrens J; Truss M; Frisch S; Reichmann E; Birchmeier W
Oncogene; 1995 Aug; 11(3):475-84. PubMed ID: 7630631
[TBL] [Abstract][Full Text] [Related]
16. [Dysfunction of cadherin cell adhesion system in cancer invasion and metastasis].
Ochiai A
Gan To Kagaku Ryoho; 1999 Mar; 26(4):565-71. PubMed ID: 10097760
[TBL] [Abstract][Full Text] [Related]
17. The interactions of APC, E-cadherin and beta-catenin in tumour development and progression.
Ilyas M; Tomlinson IP
J Pathol; 1997 Jun; 182(2):128-37. PubMed ID: 9274521
[TBL] [Abstract][Full Text] [Related]
18. Beta-catenin mutations are frequent in hepatocellular carcinomas but absent in adenomas induced by diethylnitrosamine in B6C3F1 mice.
Ogawa K; Yamada Y; Kishibe K; Ishizaki K; Tokusashi Y
Cancer Res; 1999 Apr; 59(8):1830-3. PubMed ID: 10213486
[TBL] [Abstract][Full Text] [Related]
19. No evidence for mutations in the alpha- and beta-catenin genes in human gastric and breast carcinomas.
Candidus S; Bischoff P; Becker KF; Höfler H
Cancer Res; 1996 Jan; 56(1):49-52. PubMed ID: 8548773
[TBL] [Abstract][Full Text] [Related]
20. Altered localization of E-cadherin and alpha-catenin in rat esophageal tumors.
Khare L; Sabourin CL; De Young BR; Jamasbi RJ; Stoner GD
Int J Oncol; 1999 Jan; 14(1):33-40. PubMed ID: 9863006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
